Publications by authors named "Andrej Prezelj"

Claim this Profile
P
Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro.
Petra Iglicar, Igor Legen, Gregor Vilfan, Lovro Selic, Andrej Prezelj

J Pharm Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors of beta-ketoacyl-ACP reductase from Escherichia coli.
Katja Kristan, Tomaz Bratkovic, Matej Sova, Stanislav Gobec, Andrej Prezelj

Chem Biol Interact· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor.
Susanne Paukner, Lars Hesse, Andrej Prezelj, Tomaz Solmajer, Uros Urleb

Antimicrob Agents Chemother· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 3 cytotoxicity screening assays and their application to the selection of novel antibacterial hits.
Luka Peternel, Miha Kotnik, Andrej Prezelj, Uros Urleb

J Biomol Screen· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Ivan Plantan, Lovro Selic, Tomaz Mesar, Petra Stefanic Anderluh, Marko Oblak, Andrej Prezelj

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.
Miha Kotnik, Petra Stefanic Anderluh, Andrej Prezelj

Curr Pharm Des· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in serine protease inhibitors as anticoagulant agents.
Andrej Prezelj, Petra Stefanic Anderluh, Luka Peternel, Uros Urleb

Curr Pharm Des· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics.
Andreja Kranjc, Lucija Peterlin Masic, Sebastjan Reven, Klemen Mikic, Andrej Prezelj

Eur J Med Chem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiol-reactive clenbuterol analogues conjugated to bovine serum albumin.
Marko Oblak, Andrej Prezelj, Slavko Pecar, Tom Solmajer

Z Naturforsch C J Biosci· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.
Andreja Kranjc, Lucija Peterlin-Masic, Janez Ilas, Andrej Prezelj, Mojca Stegnar

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of binding of some thiol-reactive clenbuterol analogues to bovine serum albumin by electron paramagnetic resonance spectroscopy.
Andrej Prezelj, Janez Strancar, Franc Gubensek, Slavko Pecar, Guy Degand

Anal Biochem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse of clenbuterol and its detection.
Andrej Prezelj, Ales Obreza, Slavko Pecar

Curr Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis